4-1BB Signaling Breaks the Tolerance of Maternal CD8⁺ T Cells That Are Reactive with Alloantigens

• Kwang H. Kim,

  Affiliation Division of Cancer Biology, National Cancer Center, Goyang, Kyeonggi-do, Korea

  ⨯
• Beom K. Choi,

  Affiliation Division of Cancer Biology, National Cancer Center, Goyang, Kyeonggi-do, Korea

  ⨯
• Jung D. Kim,

  Affiliation Departments of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Young H. Kim,

  Affiliation Program for Immunotherapeutic Research, National Cancer Center, Goyang, Kyeonggi-do, Korea

  ⨯
• Sun K. Lee,

  Affiliation Department of Biological Sciences, University of Ulsan, Ulsan, Korea

  ⨯
• Jae H. Suh,

  Affiliation Department of Pathology, Ulsan University Hospital, Ulsan, Korea

  ⨯
• Sang C. Lee,

  Affiliation Division of Cancer Biology, National Cancer Center, Goyang, Kyeonggi-do, Korea

  ⨯
• Sang W. Kang,

  Affiliation Department of Biological Sciences, University of Ulsan, Ulsan, Korea

  ⨯
• Byoung S. Kwon

  * E-mail: bskwon@ncc.re.kr

  Current address: Division of Cancer Biology, National Cancer Center, Goyang, Kyeonggi-do, Korea

  Affiliations Division of Cancer Biology, National Cancer Center, Goyang, Kyeonggi-do, Korea, Program for Immunotherapeutic Research, National Cancer Center, Goyang, Kyeonggi-do, Korea, Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisianna, United States of America

  ⨯